Research and Development Publications

Studies engaged by the Institute are generating evidence that will guide the practice of health care staff.  Accordingly, the current project portfolio places the Institute firmly at the forefront of local, national and international research communities that work together to generate the evidence base to improve patient care in the last hours and days of life.

MCPCIL Publication Record

MCPCIL Poster Presentations

MCPCIL Invited, Keynote and Oral Presentations

Individual Posters presented at recent conferences can be viewed below:

Association of Palliative Medicine Conference 2017

Dr Vicky Reid - Biomarkers of Dying in Cancer Patients in the Last Months of Life

James Baker - Challenging the pressure on NHS resources: could 48-hour continuous subcutaneous infusions (CSCIs) help? A systematically-structured review of the current evidence base

James Baker - The frequency at which drugs administered by continuous subcutaneous infusion are changed: a service evaluation of 7 Acute NHS hospitals in Northern England

David Cassidy - Promoting dignity and patient-centred care: evaluating the feasibility of engaging the 'Patient Dignity Question' within an Academic Palliative Care Unit

Anne Black - Patient Experience: The Real Stories

Dr Amara Nwosu - Robotic technology and palliative care education: the development of a 'Nao Robot' computer program

Dr Amara Nwosu - Hypercalcaemia of malignancy: an analysis of the medical management of palliative care patients in community, hospice and hospital settings

Dr Amara Nwosu - The development of a framework to personalise hydration management in cancer care: the use of non-invasive technology to evaluate fluid states and dehydration related symptoms


Marie Curie Conference 2016

Anne Black - A qualitative exploration of the lived experience of hospital inpatients receiving support from the Hospital Specialist Palliative Care Team (HSPCT) in one acute hospital setting

James Baker - Analysis of the Chemical Compatibility and Stability of Drug Combinations used in Continuous Subcutaneous Infusions